Descriptif de l'entité et de l'activité

Avec près de 16 500 collaborateurs, une présence dans 35 pays, un chiffre d’affaires de plus de 3,5 milliards d’euros, Air Liquide Healthcare, la branche Santé du Groupe Air Liquide, est un des leaders mondiaux dans ce domaine.

Aujourd’hui, Air Liquide Healthcare est présent à l’hôpital et au domicile des patients pour y fournir des produits, des services et des programmes d’accompagnement pour la prévention, le diagnostic et le traitement de maladies chroniques ou lors d’épisodes aigus.

 

Quelle sera votre contribution et comment vous épanouir dans ce poste ?

 

Air Liquide Healthcare is a major global provider of products and services in home healthcare, an expert in chronic disease follow up at home, and a key supplier of medical gases for hospitals.

Reporting to the VP Evidence & Access, you are responsible for market access strategies (integrated, evidence-based funding, reimbursement and pricing strategies) of Air Liquide Healthcare therapies in the Diabetes businesses worldwide (focused on but not limited to Europe) in order to expand patient access to AL offers. Air Liquide Healthcare’s therapies typically integrate services with drugs or medical devices. You will be the reference point for supporting the company’s understanding of funding and reimbursement systems and the decision criteria/frameworks of health system decision makers that govern market access to contribute to the development and execution of strategies that ensure the successful launch and uptake of company therapies.

 

You will develop market access strategies (as defined above) that demonstrate the value of the Air Liquide Healthcare portfolio to health system payers, providers and decision makers responsible for making funding & reimbursement decisions. You will lead the implementation of these strategies in close collaboration with leaders and team members from WBL Healthcare and countries (affiliates). 

Your key deliverables are to: 

- Collaborate with geography and country teams to secure and maintain timely access for ALH therapies for target populations, with optimal funding & reimbursement.

- Embed funding & reimbursement strategies into ALH R&D, clinical and commercialization processes.

- Coordinate and lead the development of Core Value Dossiers and value-based tools/summaries for priority therapies, integrating marketing strategies with evidence of clinical and economic value.

- Secure market access readiness at the affiliates levels, supporting affiliate teams’ preparation and delivery of quality funding & reimbursement submissions, and helping build affiliate market access expertise.

- Carry out payer studies and engage with stakeholders in international healthcare ecosystems.

- Anticipate changes in the delivery of healthcare in key markets and identify the most relevant funding and reimbursement strategies for ALH therapies according to different health system methodologies and payers' willingness to pay.

- Understand and articulate the relevant clinical and economic outcomes for payers, and the key features and value-added benefits for payers in order to guide technology and service developments.

- Engage with international stakeholders to understand their thinking regarding the assessment and funding/reimbursement of health technologies and services, to identify and build innovative models to ensure the added-value of ALH therapies are recognized and rewarded by payers and other health system stakeholders.

- Assess the market access readiness and needs of new therapies/offerings to contribute to company strategies.

- This is a role that involves regular business travel abroad.

 

Etes-vous LA personne faite pour ce poste ?

 

- An advanced degree such as an MBA, MPH, MHA, MS, or MSc in health economics, health policy, healthcare administration, health services research, public health, or similar discipline is strongly preferred.

- Minimum 8 years’ experience in market access, health economics or related field, preferably in the medical device and/or pharmaceutical industries, with a majority of time spent working in Europe.

- Strong technical expertise in the areas of market access and health systems, leveraging clinical and economic data to support market access.

- Strong leadership and communication skills with the ability to present complex information to a broad group of senior stakeholders in a way that is meaningful, understandable and credible to the audience.

- Demonstrated ability to collaborate with team members in developing and conveying evidence of value and facilitating patient access.

- Strong interpersonal skills including demonstrated track record developing relationships at all levels in an organization, collaborating with diverse teams, and directly influencing business objectives.

- Demonstrated ability to:

- Set and execute on priorities, manage multiple projects and produce results,

- Continuously adapt in a rapidly changing atmosphere to maintain and improve functional excellence,

- Work independently and effectively with minimal supervision.

- To be fluent in English is mandatory and to be fluent in French or in another language is a nice-to-have.

#LI-FM1

 

Nos différences font notre performance

Chez Air Liquide, nous nous engageons à créer un environnement de travail collaboratif et inclusif qui reflète la diversité de nos collaborateurs, de nos clients, des patients et de nos parties prenantes ainsi que des cultures à travers le monde.

Nous accueillons et considérons les candidatures de tous les candidats qualifiés, quel que soit leur parcours. Nous sommes convaincus qu'une organisation diversifiée permet à nos collaborateurs de révéler leur talent, à la fois individuellement et collectivement, et qu'elle contribue à renforcer notre capacité d'innovation en faisant vivre nos fondamentaux, en agissant pour le succès/la réussite du Groupe et en créant un environnement engageant, dans un monde en mutation.